These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12192718)

  • 41. Safety profile of quinolone antibiotics in the pediatric population.
    Grady R
    Pediatr Infect Dis J; 2003 Dec; 22(12):1128-32. PubMed ID: 14688586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Shigellosis.
    Niyogi SK
    J Microbiol; 2005 Apr; 43(2):133-43. PubMed ID: 15880088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Surveillance network of bacterial meningitis in children, 7 years of survey in France].
    Levy C; Bingen E; Aujard Y; Boucherat M; Floret D; Gendrel D; Cohen R;
    Arch Pediatr; 2008 Dec; 15 Suppl 3():S99-S104. PubMed ID: 19268250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of clonality in the global spread of fluoroquinolone-resistant bacteria.
    Klugman KP
    Clin Infect Dis; 2003 Mar; 36(6):783-5. PubMed ID: 12627363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated cerebrospinal fluid levels of glutamate in children with bacterial meningitis as a predictor of the development of seizures or other adverse outcomes.
    Ma W; Shang-Feaster G; Okada PJ; Kernie SG
    Pediatr Crit Care Med; 2003 Apr; 4(2):170-5. PubMed ID: 12749647
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
    Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
    Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Osteoarticular infections: therapeutic proposals of the Paediatric Infectious Diseases Group of the French Society of Paediatrics (GPIP)].
    Grimprel E; Lorrot M; Haas H; Pinquier D; Parez N; Ferroni A; Cohen R;
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S74-80. PubMed ID: 19000859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Aminopenicillin: when, how, what kind?].
    Mombelli G
    Schweiz Med Wochenschr; 1981 May; 111(18):641-5. PubMed ID: 7244588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical use of fluoroquinolones in children.
    Alghasham AA; Nahata MC
    Ann Pharmacother; 2000 Mar; 34(3):347-59; quiz 413-4. PubMed ID: 10917383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Further data referring to oxolinic acid (Gramurin) treatment of shigellosis, salmonellosis and urinary tract infections.
    Münnich D; Zarándy B; Békési I
    Ther Hung; 1984; 32(4):149-54. PubMed ID: 6571200
    [No Abstract]   [Full Text] [Related]  

  • 51. Chloramphenicol: properties and clinical use.
    Laferriere CI; Marks MI
    Pediatr Infect Dis; 1982; 1(4):257-64. PubMed ID: 7177917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Critical risk/benefit analysis of pefloxacine use in children under 15 years--the problem of arthralgias.
    Chevais M; Reinert P; Rondeau MC; Tobelem R; Albengres E; Riant P; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):306-9. PubMed ID: 3476471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quinolone use in the developing world: state of the art.
    Tupasi TE
    Drugs; 1999; 58 Suppl 2():55-9. PubMed ID: 10553707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Indications and restrictions of fluoroquinolone use in children.
    Green SD
    Br J Hosp Med; 1996 Oct 16-Nov 5; 56(8):420-3. PubMed ID: 8909718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic use of fluoroquinolone in children.
    Choi SH; Kim EY; Kim YJ
    Korean J Pediatr; 2013 May; 56(5):196-201. PubMed ID: 23741232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluoroquinolones in paediatrics: a risk for the patient or for the community?
    Gendrel D; Chalumeau M; Moulin F; Raymond J
    Lancet Infect Dis; 2003 Sep; 3(9):537-46. PubMed ID: 12954559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rational use of the fluoroquinolones.
    Richards GA; Brink AJ; Feldman C
    S Afr Med J; 2019 May; 109(6):378-381. PubMed ID: 31266554
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pediatric uses of fluoroquinolone antibiotics.
    Murray TS; Baltimore RS
    Pediatr Ann; 2007 Jun; 36(6):336-42. PubMed ID: 17727139
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Risk of Musculoskeletal Adverse Events With Fluoroquinolones in Children: What Is the Verdict Now?
    Binz J; Adler CK; So TY
    Clin Pediatr (Phila); 2016 Feb; 55(2):107-10. PubMed ID: 26260402
    [No Abstract]   [Full Text] [Related]  

  • 60. [Fluoroquinolones in pediatrics. The problem state by the start of the XXIst century].
    Padeĭskaia EN
    Antibiot Khimioter; 2004; 49(7):34-44. PubMed ID: 15690912
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.